HomeGeneticsConditionX-linked infantile spinal muscular atrophy
Back to Condition
X-linked infantile spinal muscular atrophy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

X-linked infantile spinal muscular atrophy

X-linked infantile spinal muscular atrophy is a severe, rare genetic condition affecting boys, characterized by progressive muscle weakness and respiratory failure.

Overview

X-linked infantile spinal muscular atrophy is a condition that affects only boys. It is characterized by severe muscle weakness, absent reflexes (areflexia), and joint stiffness (arthrogryposis). Due to the severity of the condition, most affected children do not survive past early childhood.

Symptoms

  • Muscle and Joint Issues: Severe weakness, joint deformities from birth, and in some cases, broken bones at birth.
  • Developmental Regression: Loss of previously acquired motor milestones, such as sitting unassisted.
  • Physical Features: Unusually small chin and abnormal curvature of the spine.
  • Respiratory Issues: Weakness of chest muscles leads to life-threatening breathing problems.
  • Other: Undescended testes (cryptorchidism).

Causes

The condition is caused by mutations in the UBA1 gene. This gene produces an enzyme necessary for protein degradation—the process of breaking down damaged or unneeded proteins. When this process fails, proteins build up inside cells, disrupting normal function and leading to the death of motor neurons, which are essential for muscle movement.

Inheritance

This condition is inherited in an X-linked recessive pattern. Because males have only one X chromosome, a single altered copy of the gene is sufficient to cause the disorder. Females, who have two X chromosomes, would require mutations in both copies to be affected, making the condition significantly more common in males. Fathers cannot pass X-linked traits to their sons.

Frequently Asked Questions

Birth‑time findings such as joint contractures (arthrogryposis), low muscle tone, and absent or diminished reflexes are key indicators. A newborn who cannot lift the head or has a small, flattened chin may warrant further evaluation. Early neurologic examination and a review of family history can prompt genetic testing.
Multidisciplinary care is essential. Respiratory support (non‑invasive ventilation or tracheostomy) can prevent life‑threatening breathing problems. Physical therapy, orthotic devices, and pain management help maintain comfort. Early involvement of a palliative care team ensures that the family’s goals guide treatment decisions. While no cure exists, these interventions can extend life and improve comfort.
definitive diagnosis requires sequencing of the UBA1 gene to identify pathogenic variants. In many cases, a whole‑exome or targeted gene panel that includes UBA1 is ordered. Prenatal testing is also available for families with a known mutation. The test results are interpreted by a clinical geneticist in the context of the patient’s clinical presentation.
Because the mutation is X‑linked recessive, carrier females can have affected sons. Genetic counseling is recommended for families. Prenatal testing or pre‑implantation genetic diagnosis (PGD) can identify embryos without the mutation. If a female is a carrier, she can also consider assisted reproductive technologies that reduce the chance of transmission.===
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA